Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

53.78 -0.32 (-0.58%)
Streaming Delayed Price Updated: 1:24 PM EDT, May 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
News headline image
2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit... 
Via StockStory
News headline image
3 Growth Stocks to Add to Your Roster
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil... 
Via StockStory
News headline image
3 Growth Stocks the Market Is Throwing Away and Why You Should Pick Them Up ↗
Don't let their current weakness deter you. Sometimes, investors collectively misread and misprice the situation. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
The 5 Most Interesting Analyst Questions From Boston Scientific’s Q1 Earnings Call
Boston Scientific’s first quarter saw a strong positive market reaction, underpinned by solid organic sales growth and improved operating margins. Management... 
Via StockStory
Topics Earnings
Boston Scientific Corp (NYSE:BSX) Offers a Textbook Example of Affordable Growth ↗
Via Chartmill
In today's session, there are S&P500 stocks with remarkable trading volume. ↗
Via Chartmill
News headline image
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory de... 
Via StockStory
Top S&P500 movers in Friday's session ↗
Via Chartmill
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
BSX Q1 Deep Dive: Market Outperformance Despite Lowered Guidance and Product-Specific Headwinds
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q1 CY2026, with sales up 11.6% year on year to $5.20 billion. O... 
Via StockStory
Boston Scientific Corp (NYSE:BSX) Reports Mixed Q1 2026 Results, Slight Revenue Miss Amid Profit Beat ↗
Via Chartmill
Boston Scientific Corp (NYSE:BSX) Presents a Compelling Growth and Technical Setup Case ↗
Via Chartmill
News headline image
1 Oversold Stock Set for a Comeback and 2 We Avoid
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investo... 
Via StockStory
Topics Bonds
News headline image
Stock Market Today, April 22: Boston Scientific Jumps After Q1 Earnings Beat Resets Growth Expectations ↗
On April 22, 2026, investors weigh a rare combo of earnings strength and softer long-term targets reshaping this medtech leader’s outlook. 
Via The Motley Fool
Topics Earnings Stocks
Discover which S&P500 stocks are making waves on Wednesday. ↗
Via Chartmill
Stay informed about the most active stocks in the S&P500 index on Wednesday's session. ↗
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session. ↗
Via Chartmill
News headline image
BSX Q2 2025 Earnings Transcript ↗
BSX Q2 2025 Earnings Transcript 
Via The Motley Fool
News headline image
BSX Q3 2025 Earnings Transcript ↗
BSX Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics World Trade
News headline image
BSX Q1 2026 Earnings Transcript ↗
BSX Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Economy World Trade
News headline image
Boston Scientific (NYSE:BSX) Surprises With Q1 CY2026 Sales
Medical device company Boston Scientific (NYSE:BSX) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 11.6% year on year to... 
Via StockStory
News headline image
Boston Scientific Stock Is Trending Today: What To Know Now ↗
Boston Scientific Corp. (NYSE:BSX) shares are in the spotlight on Tuesday after Stifel maintained a Buy rating and lowered its price target on the stock. 
Via Benzinga
News headline image
Boston Scientific (BSX) Q1 Earnings: What To Expect
Medical device company Boston Scientific (NYSE:BSX) will be reporting earnings this Wednesday before market hours. Here’s what you need to know. Boston Scien... 
Via StockStory
Topics Artificial Intelligence
Top S&P500 movers in Monday's session ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
1 Cash-Producing Stock for Long-Term Investors and 2 That Underwhelm
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
Boston Scientific’s $14.9 Billion Bet: The Strategic "Homecoming" to Neurovascular Dominance
As of April 15, 2026, the medical technology landscape is bracing for its most significant transformation in years. Boston Scientific (NYSE:BSX) is moving steadily toward the finalization of its $14.9... 
Via MarketMinute
Topics Economy
News headline image
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately... 
Via MarketMinute
Topics Economy
News headline image
Wall Street’s Renaissance: Bank of America Shatters Q1 2026 Estimates as M&A and Trading Volatility Surge
The financial landscape of 2026 has been marked by a return to high-stakes deal-making and intense market fluctuations, and no institution seems more equipped to navigate this era than Bank of America... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of... 
Via MarketMinute
Topics Bankruptcy Earnings Economy
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.